HRID2093387

反应详情

EQUATION

反应方程式

HRID 2093387 的结构方程式

PROCEDURE

实验过程

2-(2-Chloro-8-(2-hydroxypropan-2-yl)-6-morpholino-9H-purin-9-yl)ethyl acetate (300 mg) was treated with 4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine via General Procedure A and was purified via reverse phase HPLC to give 107 mg of 102 as a white solid. MS (Q1) 415.2 (M)+

WORKUP

后处理

  1. customwas purified via reverse phase HPLC